BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Early Diagnosis and Intervention in DMD - Patient #3

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Friday, May 1, 2020
Sponsor Information: 

Supported in part by an independent educational grant from PTC Therapeutics

Faculty

Aravindhan Veerapandiyan, MD
Aravindhan Veerapandiyan, MD
University of Arkansas for Medical Sciences Arkansas Children’s Hospital
Early Diagnosis and Intervention in DMD - Patient #3
Activity Overview: 

This case study will explore early diagnosis and intervention in DMD in patient #3 (9-year-old male). The focus of this case study is DMD delayed diagnosis, declined steroid treatment.

Learning Objectives: 
  • Educate providers (pediatricians, family physicians, general neurologists) about the importance of early intervention in patients with DMD​
  • The case study will examine two scenarios showing the impact of early treatment on clinical outcomes​
    • A patient who received standard of care soon after symptom onset ​
    • A patient who faced diagnostic and/or treatment delays